Utility of atezolizumab plus bevacizumab, carboplatin, and paclitaxel combination for the treatment of advanced non-squamous non-small cell lung cancer patients with malignant pleural effusion
The ABCP regimen may be a promising treatment option for non-squamous NSCLC patients with MPE.
Authors
- Takashi Hirose (ORCID: https://orcid.org/0000-0002-3713-3072)
- Kenichiro Atsumi (ORCID: https://orcid.org/0000-0003-1264-0227)
- Kakeru Hisakane (ORCID: https://orcid.org/0000-0002-9108-2050)
- Masahiro Seike (ORCID: https://orcid.org/0000-0002-1572-5472)
Institutions
- Nippon Medical School (JP)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tlcr-24-347
- Citations
- 4
- Primary Topic
- Pleural and Pulmonary Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.68